Pediatric Device R&D, Funding Collaborations Urged By Senate HELP Staffer
This article was originally published in The Gray Sheet
Executive Summary
FDA needs to refine its premarket path for pediatric devices, Vipul Mankad, MD, Robert Wood Johnson health policy fellow on the Senate HELP Committee, told participants at a June 24 Institute of Medicine panel meeting
You may also be interested in...
Pediatric Device Reforms Presented To Policymakers By Advocacy Groups
Firms modifying devices for pediatric patients should receive fast-tracked product review, according to a proposal generated by two children's organizations and other stakeholders
Pediatric Device Reforms Presented To Policymakers By Advocacy Groups
Firms modifying devices for pediatric patients should receive fast-tracked product review, according to a proposal generated by two children's organizations and other stakeholders
Pediatric Device Availability Barriers Explored In FDA Report
CDRH is teaming with the American Academy of Pediatrics to assess availability of certain devices, with an eye toward discovering which changes to existing products would enable or improve pediatric use